S1501 || Prospective Evaluation of Carvedilol vs No treatment in Prevention of Cardiac Dysfunction in Women with Metastatic HER-2+ Breast Cancer, Phase III

Prospective Evaluation of Carvedilol vs No treatment in Prevention of Cardiac Dysfunction in Women with Metastatic HER-2+ Breast Cancer, Phase III

Learn more:
http://www.clinicaltrials.gov/ct2/show/NCT03418961

Protocol Number

C-331

Phase

III (Cancer Control)

Management Group

Oncology Network

Oncology Group

Breast Oncology Group

Disease Sites

Breast - Female

Cancer Control

Sponsor Protocol

S1501

Principal Investigator

Amelia Zelnak

Scope

National

Participating Institutions

Atlanta Cancer Care - Atlanta
Atlanta Cancer Care - Cumming
Atlanta Cancer Care - Stockbridge
Georgia Cancer Specialists - Athens
Georgia Cancer Specialists - Blairsville
Georgia Cancer Specialists - Canton
Georgia Cancer Specialists - Cumming
Georgia Cancer Specialists - Decatur
Georgia Cancer Specialists - Macon
Georgia Cancer Specialists - Marietta
Georgia Cancer Specialists - Northside

Find Open Clinical Trials

Prospective Evaluation of Carvedilol vs No treatment in Prevention of Cardiac Dysfunction in Women with Metastatic HER-2+ Breast Cancer, Phase III

Want to learn more?